Graham Capital Management, L.P. Sarepta Therapeutics, Inc. Transaction History

Graham Capital Management, L.P.

  • $5.08 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$124.33 - $156.75 $712,659 - $898,491
5,732 New
5,732 $715,000
Q3 2022

Nov 14, 2022
SELL
$75.71 - $119.24 $163,760 - $257,916
-2,163 Reduced 9.38%
20,908 $2.31 Million
Q2 2022

Aug 15, 2022
BUY
$62.69 - $88.44 $1.45 Million - $2.04 Million
23,071 New
23,071 $1.73 Million

Others Institutions Holding SRPT

# of Institutions
535
Shares Held
89.8M
Call Options Held
1.66M
Put Options Held
1.44M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.45B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email